Is CareMax Inc. (NASDAQ:CMAX) an excellent stock to buy at the moment?

After finishing at $4.12 in the prior trading day, CareMax Inc. (NASDAQ: CMAX) closed at $4.11, down -0.24%. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 229934 shares were traded. CMAX stock price reached its highest trading level at $4.2000 during the session, while it also had its lowest trading level at $4.0200.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



Our goal is to gain a better understanding of CMAX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.80 and its Current Ratio is at 4.80. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.39.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 07, 2022, initiated with a Hold rating and assigned the stock a target price of $7.50.

On January 07, 2022, UBS started tracking the stock assigning a Buy rating and target price of $14.

On October 20, 2021, Jefferies started tracking the stock assigning a Buy rating and target price of $15.Jefferies initiated its Buy rating on October 20, 2021, with a $15 target price.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.62 while its Price-to-Book (P/B) ratio in mrq is 0.77.

Stock Price History:

Over the past 52 weeks, CMAX has reached a high of $9.23, while it has fallen to a 52-week low of $3.45. The 50-Day Moving Average of the stock is 6.3239, while the 200-Day Moving Average is calculated to be 6.3443.

Shares Statistics:

The stock has traded on average 338.29K shares per day over the past 3-months and 868.59k shares per day over the last 10 days, according to various share statistics. A total of 87.41M shares are outstanding, with a floating share count of 71.73M. Insiders hold about 17.93% of the company’s shares, while institutions hold 72.60% stake in the company. Shares short for CMAX as of Oct 13, 2022 were 3.86M with a Short Ratio of 4.39M, compared to 3.87M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 4.42% and a Short% of Float of 6.30%.

Earnings Estimates

Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.12, while EPS last year was -$0.03. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.02 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.05 and -$0.49 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.11, with 5 analysts recommending between $0.49 and -$0.4.

Revenue Estimates

A total of 6 analysts have provided revenue estimates for CMAX’s current fiscal year. The highest revenue estimate was $612M, while the lowest revenue estimate was $589.58M, resulting in an average revenue estimate of $595.05M. In the same quarter a year ago, actual revenue was $295.76M, up 101.20% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $739.23M in the next fiscal year. The high estimate is $816M and the low estimate is $630M. The average revenue growth estimate for next year is up 24.20% from the average revenue estimate for this year.